Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
L-Leucine; L-Valine; L-Lysine; L-Phenylalanine; L-Threonine; Tryptophan; L-Isoleucine; L-Arginine; L-Histidine; L-Aspartic acid; L-Cysteine; L-Glutamic acid; Glycine; L-Proline; L-Serine; L-Tyrosine; L-Ornithine hydrochloride; Taurine; L-Alanine; L-Methionine
Baxter Healthcare Ltd
L-Leucine; L-Valine; L-Lysine; L-Phenylalanine; L-Threonine; Tryptophan; L-Isoleucine; L-Arginine; L-Histidine; L-Aspartic acid; L-Cysteine; L-Glutamic acid; Glycine; L-Proline; L-Serine; L-Tyrosine; L-Ornithine hydrochloride; Taurine; L-Alanine; L-Methionine
10gram/1litre ; 7.6gram/1litre ; 11gram/1litre ; 4.2gram/1litre ; 3.7gram/1litre ; 2gram/1litre ; 6.7gram/1litre ; 8.4gram/1litre ; 3.8gram/1litre ; 6gram/1litre ; 1.89gram/1litre ; 10gram/1litre ; 4gram/1litre ; 3gram/1litre ; 4gram/1litre ; .45gram/1litre ; 3.18gram/1litre ; .6gram/1litre ; 8gram/1litre ; 2.4gram/1litre
Solution for infusion
Intravenous
No Controlled Drug Status
Never Valid To Prescribe As A VMP
BNF: 09030000; GTIN: 05413760278469
OBJECT 1 PRIMENE 10% Summary of Product Characteristics Updated 15-Mar-2017 | Baxter Healthcare Ltd 1. Name of the medicinal product PRIMENE 10% 2. Qualitative and quantitative composition Each litre of the infusion solution contains: L-Isoleucine L-Leucine L-Valine L-Lysine L-Methionine L-Phenylalanine L-Threonine L-Tryptophan L-Arginine L-Histidine L-Alanine L-Aspartic Acid L-Cysteine L-Glutamic Acid Glycine L-Proline L-Serine L-Tyrosine L-Ornithine Hydrochloride 6.70 g 10.00 g 7.60 g 11.00 g 2.40 g 4.20 g 3.70 g 2.00 g 8.40 g 3.80 g 8.00 g 6.00 g 1.89 g 10.00 g 4.00 g 3.00 g 4.00 g 0.45 g 3.18 g 0.60 g Taurine For the full list of excipients, see section 6.1. 3. Pharmaceutical form Solution for infusion. A clear, colourless solution. Primene 10% has a pH of 5.5 and an osmolarity of 780 mOsmol/L. 4. Clinical particulars 4.1 Therapeutic indications Primene 10% is indicated in 1) children and infants 2) neonates, at term or premature, of normal or low birth weight when oral or enteral nutrition is impossible, insufficient or contraindicated. 4.2 Posology and method of administration Posology Parenteral nutrition initiation and duration as well as dosage (dose and rate of administration) depends on a patient's • age, weight, clinical condition, • nitrogen requirements, • ability to metabolize the constituents of Primene, • additional nutrition that may be provided parenterally and/or enterally. The usual range is 1.5 – 3.5g amino-acids/kg/24 hours 0.230 – 0.53g nitrogen/kg/24 hours 15 – 35ml of Primene 10%/kg/24 hours The infusion rate should not exceed 0.05ml/kg/min. Recommended flow rates: Neonates and Infants: continuous infusion (over 24 hours). Children: continuous infusion (over 24 hours) or cyclic infusion (over about 12 hours in 24). The flow rate should be adjusted according to the dosage, the characteristics of the infusion solution, the total volume intake per 24 hours and the infusion duration. The flow rate should be increased gradually during the first hour. Method of administration Pri Read the complete document